Comparative study between monotherapy (tamsulosin 0.4mg versus tadalafil 5 mg) versus combined therapy in treatment of lower urinary tract symptoms of benign prostatic hyperplasia - Egyptian Knowledge Bank

169466

Comparative study between monotherapy (tamsulosin 0.4mg versus tadalafil 5 mg) versus combined therapy in treatment of lower urinary tract symptoms of benign prostatic hyperplasia

Article

Last updated: 28 Dec 2024

Overview Similar Items

Article

Prospective Comparative Study between Silodosin 8 mg Versus Combination of Tadalafil 5mg and Silodosin 4mgfor treatment of Lower Urinary Tract Symptoms related to Benign Prostati

Article

COMPARATIVE STUDY BETWEEN -BLOCKERS AND COMBINATION OF -BLOCKERS AND PHOSPHODIESTRASE 5- INHIBITORS IN TREATMENT OF BENIGN PROSTATIC HYPERPLASIA

Article

Safety and Efficacy of Silodosin versus Tadalafil in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms; A prospective comparative study

Article

Single Versus Double Dose Tamsulosin for Patients with Moderate or Severe Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: Prospective Randomized Study

Article

Evaluation of Silodosin in Comparison to Tamuslosin in Treatment of Benign Prostatic Hyperplasia with lower Urinary Tract Symptoms: A Prospective Study

Article

Tadalafil versus Tamsulosin as a medical expulsive therapyfor solitary unilateral lower ureteric stone less than 1 cm: a prospective randomized study.

Article

Efficacy of Silodosin versus Sildosin plus Tadalafil as medical expulsive therapy for lower ureteric stones: A prospective randomized placebo controlled study

Article

EFFECT OF TADALAFIL ADD-ON THERAPY IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC HYPERPLASIA REFRACTORY TO TAMSULOSIN MONOTHERAPY: RANDOMIZED, CONTROLLED

Article

A comparative Study of Tadalafil versus Tadalafil combined with Alpha Lipoic Acid in the treatment of Erectile Dysfunction in Diabetic Patients

Article

Prospective Randomized Controlled Study Evaluating Efficacy of Alpha-Blockers, Antimuscarinics or Combination Therapy in Relieving Ureteral Stent-Related Symptoms